News

Trump's pharmaceutical tariffs could affect some drugmakers more than others
AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...
Investornewsbreaks Fifty 1 Labs, Inc. (OTC: FITY) Completes Historic REVIVE Trial, Sets Stage For Long COVID Breakthrough And Market Expansion
Fifty 1 Labs (OTC: FITY) , through its subsidiary Fifty1 AI Labs, LLC, announced the successful completion of the REVIVE Adaptive Platform Trial (NCT ...